Photohydrolytic Technology for CIRS: How It May Improve Indoor Air for Mold, Mycotoxin, and Chemical Sensitivities
For the estimated tens of millions of people living with Chronic Inflammatory Response Syndrome (CIRS), the battle begins, and often must be won, at home. About 25% of the population carries the HLA-DR gene variants that prevent the immune system from correctly identifying and clearing mycotoxins, trapping them in a relentless inflammatory cycle. Advocates like The Biotoxin Lady (@thebiotoxinlady) have brought hard-won, personal clarity to this underdiagnosed illness, helping thousands understand that healing from CIRS requires far more than medical intervention alone. It demands a fundamentally cleaner indoor environment.
Beyond CIRS: A Family of Biotoxin-Driven Conditions
CIRS is not alone in its environmental demands. Mast Cell Activation Syndrome (MCAS), increasingly recognized as a close companion to CIRS, shares the same critical requirement: remove the biotoxin load from the living space or no lasting healing occurs.
Mycotoxin exposure from water-damaged buildings is one of the most severe and most overlooked CIRS and MCAS triggers, producing whole-body hyperreactivity that does not improve with any other intervention until the mold exposure is identified and removed. Chemical sensitivities to fragrances, pesticide residues, and volatile organic compounds activate sensitized mast cells at exposures that healthy immune systems handle without response.
Similarly, molds and mycotoxins are well-documented causes of chronic fatigue syndrome and fibromyalgia, and Multiple Chemical Sensitivity (MCS), a chronic, recurring disorder caused by a person’s inability to tolerate environmental chemicals, overlaps significantly with fibromyalgia and chronic fatigue syndrome, with symptoms improving or resolving when chemical irritants are removed. For all of these conditions, the indoor environment is not just a backdrop to the illness. It is often the engine driving it.
The Environmental Imperative in the Shoemaker Protocol
The Shoemaker Protocol, the gold-standard, evidence-based framework for CIRS, makes environmental remediation its very first step, requiring complete removal from biotoxin exposure before any downstream treatment can succeed. Dr. Ritchie Shoemaker defines CIRS as a systemic inflammatory response from exposure to the interior environment of water-damaged buildings, encompassing not just mold, but mycotoxins, bacteria, actinomycetes, endotoxins, beta-glucans, and volatile organic compounds.
Even after visible mold is remediated, a toxic mix of chemicals, fungi, and mycotoxins can remain embedded in walls, HVAC systems, and building materials, continually contaminating the air. Traditional air filters capture particulates but leave gaseous mycotoxins, pyrogens, and VOCs untouched. A more powerful, active approach is needed, one that transforms the chemistry of the entire indoor environment, not just a passive approach of filtering particles that pass through a device.
Enter Photohydrolytic Hydroxyl Oxidation (PHO)
A company called Pyure pioneered a technology that mirrors how the sun creates hydroxyl radicals outdoors, bringing that process inside where CIRS, MCAS, and MCS sufferers need it most. Pyure’s patent-protected technology mimics the way sunlight sanitizes the outdoor environment by safely generating hydroxyls indoors. These hydroxyls produce organic oxidants that disperse and treat the entire space, sanitizing the air and every surface the air contacts, including furniture, building materials, and other areas that have absorbed gaseous toxins.
The mechanism behind this is Photohydrolytic Hydroxyl Oxidation (PHO). As air passes through the reaction chamber, multiple UV frequencies induce a series of reactions with water molecules and other components of the airstream. This process yields hydroxyl radicals, a negatively charged oxygen-hydrogen molecule. Hydroxyls then interact through oxidation-reduction reactions, forming longer-lived organic oxidants. In numerous laboratory and real-world settings, these organic oxidants disperse throughout the space and render VOCs, viruses, bacteria, and mold inactive in the air and on surfaces.
For CIRS patients, this matters profoundly. These organic oxidants significantly contribute to the degradation of mycotoxins, breaking these highly toxic secondary metabolites down. The same chemistry that degrades mycotoxins also neutralizes the pyrogens, bacterial endotoxins, and the broad spectrum of VOCs that co-trigger the biotoxin pathway in CIRS, MCAS, MCS, and related conditions.
Why PHO Decisively Outperforms PCO Devices
Many CIRS patients have tried hydroxyl generators that use Photocatalytic Oxidation (PCO) air purifiers. Many have found PCO devices inadequate, and for good reason.
PCO devices use a catalyst substrate, typically titanium dioxide. Hydroxyls are formed on the substrate and do produce small amounts of organic oxidants. However, the quantity produced makes these devices effective for very small areas. As the devices are used, the substrate accumulates dust particles that further degrade hydroxyl production. The effectiveness of PCO devices depends mainly on pollutants passing through a chemical catalyst surface inside the unit. PCO technology tends to be less effective as distance increases, and it may not reach surfaces at long distances. Mycotoxins, endotoxins, and VOCs do not merely float in the air. They settle on surfaces, embed into furnishings, and are continuously re-aerosolized. In HVAC ducting, bathrooms, and other places with moisture at meaningful distance from the PCO catalyst surface may generate more toxins than can be removed.
Pyure’s PHO approach sidesteps PCO limitations entirely. Because Pyure’s UV reaction chamber contains no chemical catalyst surfaces, it avoids the catalyst degradation and proximity limitations inherent in PCO design. The hydroxyls react with VOCs to generate powerful organic oxidants that actively cascade through the entire space, reaching into HVAC ducts, bathrooms, closets, furnishings, and rooms at greater distances from the device itself. PCO devices simply cannot actively treat surfaces at distance from the device.
PHO systems can be safely and continuously operated in the presence of people, animals, plants, and furnishings. They do not degrade materials. They do not damage or yellow plastics, harden rubber, or bleach fabrics. Pyure has an FDA Class II cleared device, and Steris, a company that designs hospital operating rooms, includes Pyure equipment in their designs. In addition, Pyure systems are in hospitals, assisted living facilities, dentist offices, hotels, casinos, food and beverage manufacturing, and many other applications. Independent evaluation confirmed no harmful byproducts, and a 13-week mammalian safety study found no adverse health effects at therapeutic levels.
PCO units also carry a notable risk. PCO reactions, in the process of breaking down VOC gases, can create new VOC gases such as formaldehyde, since these compounds break down through intermediate steps before becoming nonreactive substances. For chemically sensitive CIRS or MCS patients, generating new irritants during remediation is an unacceptable tradeoff.
Understanding the Initial Treatment Phase
One important nuance for environmentally sensitive individuals: when a space carries a very heavy load of mycotoxins, pyrogens, and VOCs accumulated over months or years, even hydroxyl technology can produce intermediate VOCs during the initial breakdown process. These transient byproducts can be irritating to highly sensitized CIRS, MCAS, and MCS sufferers in the early days of treatment. This is not a flaw. It is the chemistry working.
With the right number of properly sized hydroxyl units running continuously, this transitional phase typically resolves within 3 to 14 days, as the intermediate compounds are themselves decomposed by the ongoing oxidant cascade. Because of their lower capacity for generating hydroxyls, and shorter effective range, PCO devices tend to have longer periods for getting ahead of the toxin load. Once past this initial remediation window, PHO devices running continuously can maintain a dramatically cleaner environment, preventing the re-accumulation of mycotoxins, pyrogens, and VOCs over time. The key for CIRS, MCAS, and MCS is to run the hydroxyl systems continuously to stay ahead of any new toxins that begin to be generated.
A Tool for the Healing Environment
The Shoemaker Protocol is unambiguous: you cannot begin to heal while still being exposed to environmental toxins. It is always the case that homeowners need to identify and correct moisture issues, remediate mold, and remove sources of toxins. However, for CIRS, MCAS, MCS, and related sufferers who have completed physical remediation but continue to react to residual mycotoxins, pyrogens, and VOCs, Pyure PHO devices represent a meaningful, science-backed complement to the environmental clearance process. By continuously generating and dispersing hydroxyls that reach every surface in a space, PHO technology addresses the full spatial burden of indoor biotoxin contamination, including the hard-to-reach places where PCO devices fall short.
For the biotoxin illness community fighting to reclaim safe spaces, that distinction is not a technicality. It is everything.
Note: Pyure PHO technology is intended as an environmental air and surface treatment tool. It is not a substitute for professional environmental remediation, medical diagnosis, or treatment under the Shoemaker Protocol or guidance of a qualified physician. Individuals with CIRS, MCAS, or related conditions should work with a certified clinician and Indoor Environmental Professional.